|
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes, or its employees that the report constitutes an admission that the product, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.H11 additional narrative: h3, h6 investigation summary: no device associated with this report was received for examination.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.Additional complaint information monitoring for potential safety signals will be conducted through complaint trending as part of the post-market surveillance.If additional information is made available, the investigation will be updated as applicable.The product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A manufacturing records evaluation (mre) was not performed.
|
|
It was reported that the patient presented with progressive lucent lines around components and pain, suggesting failed fixation.Implants were removed uneventfully and reimplanted with new components.Frozen section was negative for infection.Cement had not adhered to the bone, but the tibial sleeve was well fixed and thus left in place.The femoral components had been revised on (b)(6) 2024 for failed ingrowth and a cemented stem was placed at that time.Poly was revised (b)(6) 2024 when excessive scar tissue was removed.Affected side: right knee.
|